Eterna Therapeutics
ERNA
£1.34
Share price
-5.79%
Change (1 day)
-4.94%
Change (1 year)
Categories
Operating Margin for Eterna Therapeutics (ERNA)
Operating Margin as of July 2025 (TTM): -6,475.42%
According to Eterna Therapeutics's latest financial reports and stock price the company's current Operating Margin is -6,475.42%. At the end of 2024 the company had an Operating Margin of -7,647.59%.
Operating Margin history for Eterna Therapeutics from 2024 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2024 | -7,647.59% | -76% |
| 2023 | -31,869.12% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Baxter BAX | -5.98% | -99.91% | 🇺🇸 USA |
 Geron GERN | -226.73% | -96.50% | 🇺🇸 USA |
 Omeros Corporation OMER | -467.67% | -92.78% | 🇺🇸 USA |
 Sanofi SNY | 15.12% | -100.23% | 🇫🇷 France |
 Bio-Techne TECH | 16.02% | -100.25% | 🇺🇸 USA |
 Genetic Technologies GENE | -156.78% | -97.58% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | -7.76% | -99.88% | 🇮🇱 Israel |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.